Menu
Back to Journals » Clinical Ophthalmology » Volume 15
Original Research
Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,048 | Dovepress* | 4,638+ | 361 | 4,999 | |
| PubMed Central* | 410 | 153 | 563 | ||
| Totals | 5,048 | 514 | 5,562 | ||
| *Since 13 July 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar